CTX-M, TEM, and SHV Genes in Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp Isolated from Hematologic Cancer Patients with Bacteremia in Uganda
Margaret Lubwama,David Kateete,George Katende,Edgar Kigozi,Jackson Orem,Warren Phipps,Freddie Bwanga
DOI: https://doi.org/10.2147/idr.s442646
2024-02-17
Infection and Drug Resistance
Abstract:Margaret Lubwama, 1 David P Kateete, 2 George Katende, 1 Edgar Kigozi, 2 Jackson Orem, 3 Warren Phipps, 4, 5 Freddie Bwanga 2 1 Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda; 2 Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda; 3 Uganda Cancer Institute, Kampala, Uganda; 4 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; 5 Allergy and Infectious Diseases Division, Department of Medicine, University of Washington, Seattle, WA, USA Correspondence: Margaret Lubwama, Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, P. O Box 7072, Kampala, Uganda, Tel +256 774 440 332, Email Purpose: We determined the phenotypic resistance to third-generation cephalosporins, phenotypic extended spectrum beta-lactamase (ESBL) prevalence, and genotypic prevalence of ESBL-encoding genes bla CTX-M , bla TEM , and bla SHV in Enterobacteriaceae isolated from hematologic cancer patients with febrile neutropenia and bacteremia at the Uganda Cancer Institute (UCI). Patients and Methods: Blood cultures from hematologic cancer patients with febrile neutropenia were processed in BACTEC 9120. E. coli, K. pneumoniae, and Enterobacter spp . isolates were identified using conventional biochemical methods. Antimicrobial susceptibility tests, phenotypic ESBL characterization, and genotypic characterization of the ESBL-encoding genes bla CTX-M , bla TEM , and bla SHV were determined for pure isolates of E. coli, K. pneumoniae, and Enterobacter spp . Results: Two hundred and two patients were included in the study. Median age of patients was 19 years (IQR: 10– 30 years). Majority (N=119, 59%) were male patients. Sixty (30%) of the participants had at least one febrile episode due to Enterobacteriaceae. Eighty-three organisms were isolated with E. coli being predominant (45, 54%). Seventy-nine (95%) Enterobacteriaceae were multidrug resistant. The ESBL phenotype was detected in 54/73 (74%) of Enterobacteriaceae that were resistant to third-generation cephalosporins. A higher proportion of Enterobacteriaceae with ESBL-positive phenotype were resistant to piperacillin-tazobactam (p=0.024), gentamicin (p=0.000), ciprofloxacin (p=0.000), and cotrimoxazole (p=0.000) compared to Enterobacteriaceae, which were sensitive to third-generation cephalosporins. The organisms were more susceptible to carbapenems and chloramphenicol than resistant. ESBL-encoding genes ( bla CTX-M , bla TEM , and bla SHV ) were detected in 55 (75%) of the 73 Enterobacteriaceae that were resistant to third-generation cephalosporins. Bla CTX-M , was the most common ESBL-encoding gene identified with 50 (91%). Conclusion: ESBL-producing Enterobacteriaceae are a predominant cause of bacteremia in hematologic cancer patients at UCI. The most common ESBL-encoding gene identified in the ESBL-PE was bla CTX-M . Resistance to imipenem and meropenem was low. Keywords: antimicrobial resistance, extended spectrum beta-lactamases, enterobacteriaceae, CTX-M, Uganda, cancer Bacteremia is a cause of significant morbidity and mortality in patients with hematologic malignancies. This has been worsened over the past decades by an increase in the number of infections caused by multidrug resistant (MDR) strains, which have been associated with increased morbidity, mortality, and hospital costs. 1 The emergence and spread of MDR bacteria make antibiotics inefficient and infectious diseases more difficult to treat. This threatens the ability to perform life-saving procedures, including providing chemotherapy to cancer patients. 2 Among the organisms listed as the main cause of bacteremia are the extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE), including E. coli, K. pneumoniae, Enterobacter spp., Citrobacter spp ., and Proteus spp . 3–8 ESBL-PE are listed by the World Health Organization (WHO) in the critical group as one of the priority pathogens for research and development of new antibiotics. 9 The Centers for Disease Control and Prevention (CDC) has listed them as serious threats. According to the CDC, cases of ESBL-PE have increased since 2012, with 197,400 estimated cases in hospitalized patients in 2017 -Abstract Truncated-
pharmacology & pharmacy,infectious diseases